financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Cuts Opinion On Shares Of Mondelez International Inc. To Hold From Buy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Cuts Opinion On Shares Of Mondelez International Inc. To Hold From Buy
May 1, 2024 6:29 AM

09:00 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We cut our 12-month target to $72 from $81, 21.1x our '24 EPS of $3.41 (cut from $3.50; '25 cut to $3.62 from $3.75) and in line with MDLZ's long-term mean. Q1 adj-EPS of $0.95 (+11% Y/Y) was $0.06 above consensus, driven by strong gross margins (+290 bps Y/Y to 39.1% vs. our 37.9% estimate). Margins should see softness in the back half of the year as higher cocoa costs flow into the income statement. MDLZ is fully covered in terms of cocoa needs for '24 (at a much lower price than current market) and is being selective in covering its '25 cocoa needs, as it believes cocoa prices will correct sometime this fall. MDLZ kept its full-year outlook unchanged, but we sense some downside risk given expanding elasticities in chocolate, softness in U.S. biscuit (e.g., Chips Ahoy), ongoing customer disruptions in Europe, and political unrest in the Middle East. Positives include strong share buybacks ($0.6B repurchased in Q1 and $2B expected for the year vs. $1.5B in '23) and a solid balance sheet (2.5x leverage ratio).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Mar 24, 2025
03:25 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month price target of $19 is based on 15.2x our FY 26 (Mar.) EPS estimate and in line with the company's three-year average forward P/E multiple of...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Mar 24, 2025
04:45 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $331 from $304 based on our Net Present Value (NPV) analysis. We lower our 2025 EPS estimate to -$1.62 from $0.30 our 2026 EPS...
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Mar 24, 2025
01:35 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our USD8 target (2x 2025 P/B) and Strong Sell rating on XPeng ( XPEV ). The company reported 2024 revenue growth of 33.2% to CNY40.87B, with gross margin...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Mar 24, 2025
02:15 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $16 to $216, 20x (from 19x) our FY 26 (May) EPS of $10.83 (from $10.50) and in line with its three-year historical average forward...
Copyright 2023-2026 - www.financetom.com All Rights Reserved